Report #2842870

Overview

Sex

Unknown

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

intramuscular administration of Priorix-inappropriate route of administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix (intramuscular). On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: intramuscular administration of Priorix-inappropriate route of administration). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-MAY-2025 Anonymous healthcare provider called to report the maladministration of Priorix, it was given Intramuscularly instead of subcutaneously, which led to subcutaneous injection formulation administered by other route. No vaccination date, no vaccine detail and no patient demographics were obtained in this call. No further information was obtained in this call.